Noncalcified ductal carcinoma in situ: Imaging and histologic findings in 36 tumors

Journal of Ultrasound in Medicine

Volumn 28, Issue 7, 2009, Pages 903-910

  Jae, Hwan Kim ^a   Eun, Sook Ko ^a,c   Do, Youn Kim ^b   Han, Heon ^c   Sohn, Jeong Hee ^c   Du, Hwan Choe ^a  

^a Korea Cancer Center Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Breast neoplasm; Ductal carcinoma in situ; Mammography; Prognosis; Sonography

Indexed keywords

MAMMOGRAPHY; MEDICAL IMAGING; TUMORS; ULTRASONOGRAPHY;

AMERICAN COLLEGE OF RADIOLOGIES; BIOLOGICAL MARKERS; BREAST IMAGING REPORTING AND DATA SYSTEMS; BREAST NEOPLASM; DUCTAL CARCINOMA IN SITU; FALSE NEGATIVES; PROGNOSIS; SONOGRAPHIC FINDINGS;

DIAGNOSIS;

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ECHOMAMMOGRAPHY; FALSE NEGATIVE RESULT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL INFORMATION; MEDICAL RECORD REVIEW; PROTEIN EXPRESSION;

EID: 67649757592     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2009.28.7.903     Document Type: Article

References (27)

1. Schnitt SJ, Silen W, Sadowsky NL, Connolly JL, Harris JR. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med 1988; 318:898-903.
2. Tabar L, Vitak B, Chen HH, et al. The Swedish Two-County Trial twenty years later: updated mortality results and new insights from long-term follow-up. Radiol Clin North Am 2000; 38:625-651. (Pubitemid 30640056)
3. Dershaw DD, Abramson A, Kinne DW. Ductal carcinoma in situ: mammographic findings and clinical implications. Radiology 1989; 170:411-415. (Pubitemid 19035664)
4. Stomper PC, Connolly JL, Meyer JE, Harris JR. Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. Radiology 1989; 172:235-241. (Pubitemid 19192515)
5. Tabar L, Gad A, Parsons WC, Neeland DB. Mammographic appearances of in situ carcinomas. In: Silverstein MJ (ed). Ductal Carcinoma In Situ of the Breast. Baltimore, MD: Williams & Wilkins; 1997:95-117.
6. Evans A, Pinder S, Wilson R, et al. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. AJR Am J Roentgenol 1994; 162:1307-1311. (Pubitemid 24187477)
7. Ikeda DM, Andersson I. Ductal carcinoma in situ: atypical mammographic appearances. Radiology 1989; 172:661-666. (Pubitemid 19211578)
8. Mitnick JS, Roses DF, Harris MN, Feiner HD. Circumscribed intraductal carcinoma of the breast. Radiology 1989; 170:423-425. (Pubitemid 19035666)
9. Cho KR, Seo BK, Kim CH, et al. Non-calcified ductal carcinoma in situ: ultrasound and mammographic findings correlated with histological findings. Yonsei Med J 2008; 49:103-110.
10. Feig SA. Ductal carcinoma in situ: implications for screening mammography. Radiol Clin North Am 2000; 38:653-668. (Pubitemid 30640057)
11. Silverstein MJ, Parker R, Grotting JC, Cote RJ, Russell CA. Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies. J Am Coll Surg 2001; 192:196-214. (Pubitemid 32155212)
12. DiPiro PJ, Meyer JE, Denison CM, Frenna TH, Harvey SC, Smith DN. Image-guided core breast biopsy of ductal carcinoma in situ presenting as a non-calcified abnormality. Eur J Radiol 1999; 30:231-236. (Pubitemid 29343742)
13. Moon WK, Myung JS, Lee YJ, Park IA, Noh DY, Im JG. US of ductal carcinoma in situ. Radiographics 2002; 22:269-280.
14. American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS). 4th ed. Reston, VA: American College of Radiology; 2003.
15. Silverstein MJ, Poller DN, Waisman JR, et al. Prognostic classification of breast ductal carcinoma-in-situ. Lancet 1995; 345:1154-1157.
16. Holland R, Peterse JL, Millis RR, et al. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Pathol 1994; 11:167-180. (Pubitemid 24308077)
17. Fisher B, Costantino J, Redmond C, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993; 328:1581-1586. (Pubitemid 23151917)
18. Julien JP, Bijker N, Fentiman IS, et al. Radiotherapy in breastconserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase III trial 10853. EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. Lancet 2000; 355:528-533. (Pubitemid 30088672)
19. Fisher ER, Dignam J, Tan-Chiu E, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999; 86:429-438. (Pubitemid 29347405)
20. Rosen PP. Rosen's Breast Pathology. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001.
21. Pegram MD, Konecny GE, O'Callaghan C, Beryt M, Pietras R, Slamon DJ. Rational combinations of trastuzumab with chemotherapeutic drugs used in the treatment of breast cancer. J Natl Cancer Inst 2004; 96:739-749. (Pubitemid 38771819)
22. Ringberg A, Anagnostaki L, Anderson H, et al. Cell biological factors in ductal carcinoma in situ (DCIS) of the breast: relationship to ipsilateral local recurrence and histopathological characteristics. Eur J Cancer 2001; 37:1514-1522. (Pubitemid 32744682)
23. Zafrani B, Leroyer A, Fourquet A, et al. Mammographically-detected ductal in situ carcinoma of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erbB-2 proteins, and proliferative activity. Semin Diagn Pathol 1994; 11:208-214.
24. Claus EB, Chu P, Howe CL, et al. Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2/neu and hormone receptors. Exp Mol Pathol 2001; 70:303-316. (Pubitemid 32607203)
25. Bose S, Lesser ML, Norton L, Rosen PP. Immunophenotype of intraductal carcinoma. Arch Pathol Lab Med 1996; 120:81-85. (Pubitemid 26021425)
26. Karayiannakis AJ, Bastounis EA, Chatzigianni EB, Makri GG, Alexiou D, Karamanakos P. Immunohistochemical detection of oestrogen receptors in ductal carcinoma in situ of the breast. Eur J Surg Oncol 1996; 22:578-582. (Pubitemid 27036196)
27. Albonico G, Querzoli P, Ferretti S, Magri E, Nenci I. Biophenotypes of breast carcinoma in situ defined by image analysis of biological parameters. Pathol Res Pract 1996; 192:117-123. (Pubitemid 26104323)